NEW YORK, Aug. 23 - With its functional-proteomics tools and nucleic-acid diagnostics ready to roll, EraGen Biosciences has completed building up its executive-management team.
Yesterday the company said Samraat Raha, former vice president of discovery services at Incyte Genomics, would be its first chief business officer, and earlier this month it hired Gary Madsen, a former manager at Abbott Labs, to be chief technical officer.
EraGen had named its first president and CEO, former GlaxoSmithKline executive Irene Hrusovsky, in February.
The firm said it is close to naming a new vice president of finance and a vice president of technical development and manufacturing.
EraGen's technology includes the Master Catalog proteomics data-mining and -analysis tool, the MultiCode and GeneCode genotyping tools, and the EraCode molecular recognition technology.
"Our next step is really to try and coordinate all the new people, try to work on the new goals that we have set," said Carly Owen, Hrusovsky's assistant.
It was not immediately clear when the company would begin rolling out its technology.